Oncology Institute Inc (TOI) is 10.98% away from 50-day simple Moving Average despite all headwinds

Shaun Noe

As on Wednesday, Oncology Institute Inc (NASDAQ: TOI) got off with the flyer as it spiked 3.93% to $3.97, before settling in for the price of $3.82 at the close. Taking a more long-term approach, TOI posted a 52-week range of $0.13-$4.50.

Nevertheless, stock’s Earnings Per Share (EPS) this year is 24.88%. This publicly-traded company’s shares outstanding now amounts to $93.28 million, simultaneously with a float of $55.22 million. The organization now has a market capitalization sitting at $371.22 million. At the time of writing, stock’s 50-day Moving Average stood at $3.58, while the 200-day Moving Average is $2.22.

Oncology Institute Inc (TOI) Ownership Facts and Figures

Another important factor to analyze is how key investors are playing towards the stock of the Medical Care Facilities industry. Oncology Institute Inc’s current insider ownership accounts for 40.95%, in contrast to 30.17% institutional ownership. According to the most recent insider trade that took place on Sep 04 ’25, this organization’s Director sold 6,018,168 shares at the rate of 3.09, making the entire transaction reach 18,596,139 in total value, affecting insider ownership by 7,932,389. Preceding that transaction, on Sep 04 ’25, Company’s Director sold 681,832 for 3.09, making the whole transaction’s value amount to 2,106,861. This particular insider is now the holder of 590,892 in total.

Oncology Institute Inc (TOI) Earnings and Revenue Records

Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.

Oncology Institute Inc’s EPS increase for this current 12-month fiscal period is 24.88% and is forecasted to reach -0.29 in the upcoming year.

Oncology Institute Inc (NASDAQ: TOI) Trading Performance Indicators

Let’s observe the current performance indicators for Oncology Institute Inc (TOI). It’s Quick Ratio in the last reported quarter now stands at 1.37. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.87.

In the same vein, TOI’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.68, a figure that is expected to reach -0.11 in the next quarter, and analysts are predicting that it will be -0.29 at the market close of one year from today.

Technical Analysis of Oncology Institute Inc (TOI)

Through scrutinizing the latest numbers posted by the [Oncology Institute Inc, TOI], it can be observed that its last 5-days Average volume of 1.72 million was better the volume of 1.5 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 89.26% While, its Average True Range was 76.54.

Raw Stochastic average of Oncology Institute Inc (TOI) in the period of the previous 100 days is set at 78.67%, which indicates a major fall in contrast to 98.91% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.23 that was lower than 0.26 volatility it exhibited in the past 100-days period.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.